Amyloidosis

Zaki Akhtar , Lisa WM Leung , Christos Kontogiannis , et al

Read time: 26m 9s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore

Watch time: 8m 12s

Peter P Swoboda , Adam K McDiarmid , Stephen P Page , et al

Read time: 13m 20s

Jason N Dungu

ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 17m 25s
2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation

Michelle Kittleson

Watch time: 4m

Sophie Mavrogeni , George Markousis-Mavrogenis , Genovefa Kolovou

Read time: 20m
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana

Watch time: 8m 1s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana

Watch time: 3m 11s
ESC 23: ATTRibute-CM Trial

Julian Gillmore

Watch time: 4m 39s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi

Watch time: 13m 32s
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson

Watch time: 6m 19s

Media

2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation

Michelle Kittleson

Watch time: 4m
HF 22: HELIOS-A: Vutrisiran in Patients with hATTR Amyloidosis

Watch time: 4m 42s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore

Watch time: 8m 12s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill

Watch time: 5m 44s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi

Watch time: 13m 32s
ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 17m 25s
AHA 24: Nexiguran Ziclumeran for ATTR-CM

Marianna Fontana

Watch time: 5m 6s
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s
ESC 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 13m 47s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana

Watch time: 3m 11s
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Michelle Kittleson

Watch time: 6m 19s
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana

Watch time: 8m 1s

Articles

Arrhythmias in Chronic Kidney Disease

Zaki Akhtar

,

Lisa WM Leung

,

Christos Kontogiannis

,

Isaac Chung

,

Khalid Bin Waleed

,

Mark M Gallagher

,

Published:

07 March 2022

Citation:

European Cardiology Review 2022;17:e05.

DOI:

https://doi.org/10.15420/ecr.2021.52
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5366
  • Downloads: Downloads 225
  • Citations: 18
  • Read time: 26m 9s

Role of T1 Mapping in Inherited Cardiomyopathies

Peter P Swoboda

,

Adam K McDiarmid

,

Stephen P Page

,

John P Greenwood

,

Sven Plein

,

Citation:

European Cardiology Review 2016;11(2):96–101

DOI:

https://doi.org/10.15420/ecr/2016:28:2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2444
  • Downloads: Downloads 10
  • Citations: 13
  • Read time: 13m 20s

Cardiac Amyloid – An Update

Jason N Dungu

,

Citation:

European Cardiology Review 2015;10(2):113–7

DOI:

https://doi.org/10.15420/ecr.2015.10.2.113
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2202
  • Downloads: Downloads 12
  • Citations: 4

Clinical Use of Cardiac Magnetic Resonance in Systemic Heart Disease

Sophie Mavrogeni

,

George Markousis-Mavrogenis

,

Genovefa Kolovou

,

Citation:

European Cardiology Review 2014;9(1):21–7

DOI:

https://doi.org/10.15420/ecr.2014.9.1.21
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1309
  • Downloads: Downloads 2
  • Citations: 3
  • Read time: 20m